Concepedia

Raymond J. Gonzalez

RJ

Statistics

Publications

5

Citations

379

H-Index

5

Active since

2001

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Eli Lilly (United States)

University of the Sciences

Raymond J. Gonzalez is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and biochemistry.

Top concepts

Publications per year

2001–2019

5

Publications

5

Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity

Raymond J. Gonzalez, Joan B. Tarloff · Toxicology in Vitro · 2001 · 257 citations

, , +14

Nonclinical Safety Biomarkers of Drug-induced Vascular Injury

Igor Mikaelian, Mark J. Cameron, Deidre A. Dalmas et al. · Toxicologic Pathology · 2014 · 46 citations

, , +17

A Performance Evaluation of Three Drug-Induced Liver Injury Biomarkers in the Rat: Alpha-Glutathione S-Transferase, Arginase 1, and 4-Hydroxyphenyl-Pyruvate Dioxygenase

Wendy J. Bailey, Dan Holder, Hima Patel et al. · Toxicological Sciences · 2012 · 45 citations

, , +25

Can Galactose Be Converted to Glucose in HepG2 Cells? Improving the <i>in Vitro</i> Mitochondrial Toxicity Assay for the Assessment of Drug Induced Liver Injury

Qiuwei Xu, Liping Liu, Heather Vu et al. · Chemical Research in Toxicology · 2019 · 20 citations

Expression and activities of several drug-metabolizing enzymes in LLC-PK1 cells

Raymond J. Gonzalez, Joan B. Tarloff · Toxicology in Vitro · 2004 · 11 citations

, , +7

1–5 of 5